Search

everythinglearnresearchcommunity

for

Search:↓

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Finasteride metabolites found in pigs match human studies, making pigs a valid model for human drug research.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Extracts from Alnus sibirica and oregonin may help with hair growth and prevent hair loss.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

Finasteride reduces hair growth and is safe for women with excessive hair.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Finasteride effectively treats BPH, but needs more trials to understand potential.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Birth control pills can help reduce mild to moderate acne in women.

Dutasteride and finasteride affect different cell types differently.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Finasteride and metformin both help treat PCOS, but using them together works best.